Aug 14, 2020 in News, Press Releases

XPhyto Announces OTCQB Venture Market Listing

Vancouver, Canada (August 14, 2020) – XPhyto Therapeutics Corp. (CSE:XPHY / OTCQB:XPHYF / FSE:4XT) (“XPhyto” or the “Company”), a next generation bioscience company, is pleased to announce that its common shares are now trading on the OTCQB Venture Market (“OTCQB Venture”) under the stock symbol “XPHYF”.

The OTCQB Venture is the premiere marketplace for early stage and developing U.S. and international companies. Participating companies must be current in their reporting and undergo an annual verification and management certification process. Investors can find real-time quote and market information at https://www.otcmarkets.com/stock/XPHYF/overview.

XPhyto is also pleased to announce that its common shares are eligible for electronic settlement and transfer in the United States by The Depository Trust Company (“DTC”).

XPhyto’s common shares will continue to trade on the Canadian Securities Exchange (“CSE”) under the symbol “XPHY” as well as the Frankfurt Stock Exchange under the symbol “4XT”

Media Inquiries North America
Mr. Knox Henderson
T: 604-551-2360
E: info@xphyto.com

Media Inquiries Europe
MC Services AG
Julia Hofmann, Andreas Jungfer
T: +49 89 210 228 0
E: xphyto@mc-services.eu